Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

301–325 of 832 articles for Checkpoints

Then save them, add them to a collection or cite them together.
  1. Mini review · 31 Aug 2022

    Research on Anti-Cancer Therapies

    Translational Biomedicine · Volume 13, Issue 8

    Despite immune checkpoint blockade's unnoticed effectiveness in providing certain non-small-cell lung cancer NSCLC patients with long-lasting responses, the majority of patients do not react. There ... response rates to…

  2. Case report · 23 Aug 2022

    Across Differential Diagnosis between Pseudoprogression and Hyperprogression to Immunotherapy in Non-Small Cell Lung Cancer: A Case Report of Unusual Symptomatic Pseudoprogression

    Clinical Oncology: Case Reports · Volume 5, Issue 8

    Background: Immune Checkpoint Inhibitors (ICIs) administered in first-line monotherapy are the standard treatment for patients with Non-Small-Cell Lung Cancer (NSCLC) and a high expression of Programmed Cell

  3. Research article · 7 Jul 2022

    The Risk of Ocular Adverse Events after Anti-PD-1/PD-L1 Antibodies is Dose-independent: A Preliminary Report of a Prospective Observation

    Journal of Clinical and Experimental Ophthalmology · Volume 13, Issue 7

    Background: Immune Checkpoint Inhibitors (ICIs) cause ICI-related Adverse Events (irAEs) such as dry eye and uveitis, which can be severe, sometimes necessitating the suspension of ICI treatment. Retrospective studies

  4. Case report · 10 Mar 2021

    Successful Treatment with Rituximab of Sjögren’s Syndrome-Associated Organizing Pneumonia in a Patient Treated with PD-L1 Blockade for Ovarian Cancer

    Clinical Oncology: Case Reports · Volume 4, Issue 3

    immune checkpoint inhibitors in cancer therapy increases across a wide range of tumor types, rarer toxicities including rheumatologic immune adverse events are reported with increasing frequency. We describe the case

  5. Conference abstract · 17 Sep 2018

    Effects of newer anti-cancer agents on the kidney

    management of cancer patients with the approval of molecularly targeted agents and immune checkpoint inhibitors for a variety of malignancies. Further, in 2017, we saw the advent ... indicated. Acute interstitial…

  6. Review article · 2016

    Immunological Synapse Molecules

    Journal of Immunobiology · Volume 1, Issue 3

    These molecules include antigen presenting molecules, adhesion molecules, co-stimulatory molecules, and inhibitors or checkpoint molecules, etc. The spatial and temporal changes of these molecules determine the…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels